Joe Rogan TRT: What It Would Cost a Non-Celebrity

What Joe Rogan Has Actually Said About TRT

Joe Rogan has been transparent about using TRT for years. On episode 1701 of The Joe Rogan Experience (with Sanjay Gupta, 2021) and in multiple other appearances, he described testosterone as part of his regular health stack, alongside human growth hormone, NAD+ infusions, and peptides. These are firsthand, on-record statements, not tabloid inference.

His framing is consistent: he views TRT as correcting an age-related hormonal decline rather than performance enhancement. That framing aligns with how the Endocrine Society defines hypogonadism in its 2018 Clinical Practice Guideline, which states that TRT is indicated for men with "consistently low serum testosterone concentrations and symptoms or signs of androgen deficiency." [1]

What "TRT" Means Clinically

Testosterone replacement therapy covers several delivery methods. The most common in the United States are intramuscular or subcutaneous injections (testosterone cypionate or enanthate), transdermal gels, and pellets implanted under the skin. Rogan has referenced injections in podcast discussions, which matches the most cost-effective and widely prescribed format.

A standard starting dose in clinical practice is 100 to 200 mg of testosterone cypionate given intramuscularly once weekly or split twice weekly. The Endocrine Society guideline recommends titrating to a mid-normal range serum testosterone of roughly 400 to 700 ng/dL. [1]

Why Men Seek TRT

Hypogonadism affects an estimated 2 to 6 million men in the United States, though many go undiagnosed. [2] Symptoms include fatigue, reduced libido, loss of lean muscle mass, and mood changes. A 2018 analysis in the Journal of Clinical Endocrinology and Metabolism found that testosterone levels in American men have declined by roughly 1% per year since the 1980s, independent of aging. [3] That population-level trend is part of why TRT prescriptions have grown sharply over the past two decades.

The Actual Cost of TRT for a Non-Celebrity

Most people hear "Joe Rogan's protocol" and assume it requires a celebrity budget. The testosterone itself does not. The ancillary costs, primarily monitoring labs and physician oversight, are where the real variability lies.

Testosterone Cypionate: The Drug Cost

Generic testosterone cypionate is among the least expensive prescription medications in America. A 10 mL vial at 200 mg/mL (providing roughly 10 weeks of therapy at 200 mg/week, or 20 weeks at 100 mg/week) costs $30 to $80 at most retail pharmacies with a GoodRx coupon. [4] That translates to a drug-only cost of $40 to $80 per month for a standard protocol.

Brand-name injectable testosterone or newer formulations like testosterone undecanoate (Aveed, given every 10 weeks) cost substantially more: Aveed carries a list price above $1,000 per injection before insurance adjustments. [5]

Clinic and Monitoring Costs

The drug is cheap. The medical oversight is not free. An FDA-cleared TRT protocol requires:

• Baseline labs: total testosterone, free testosterone, LH, FSH, hematocrit, PSA, comprehensive metabolic panel
• Follow-up labs at 3 months, then every 6 months once stable
• Annual digital rectal exam or PSA surveillance per AUA guidelines [6]

At a direct-pay telehealth TRT clinic, monthly membership fees run $99 to $199 per month and typically bundle the prescription, shipping, and quarterly labs. At a traditional urology or endocrinology practice billed through insurance, out-of-pocket costs vary widely but a new-patient visit plus baseline labs can exceed $400 without coverage.

Telehealth vs. Traditional Clinic Breakdown

| Pathway | Monthly Drug Cost | Monthly Clinic/Lab Cost | Estimated Monthly Total | |---|---|---|---| | Retail pharmacy + PCP | $40, $80 | $20, $60 (labs amortized) | $60, $140 | | Telehealth TRT clinic | Included | Included in membership | $99, $199 | | Men's health specialty clinic | $40, $80 | $80, $200 | $120, $280 | | Concierge/celebrity-tier clinic | $200, $600 | $300, $800 | $500, $1,400 |

The bottom row approximates the concierge-medicine tier that Rogan almost certainly uses, given his access and stated emphasis on optimization medicine. The top three rows represent realistic options for most Americans.

NAD+ Infusions: The High-Cost Add-On

Rogan has repeatedly mentioned intravenous NAD+ (nicotinamide adenine dinucleotide) as part of his recovery and longevity stack. NAD+ is a coenzyme involved in cellular energy metabolism and DNA repair. Its clinical status is worth stating clearly: NAD+ IV infusions are not FDA-approved for any indication and are provided under general wellness or compounding frameworks.

What the Research Shows

Preclinical data in animals have shown NAD+ precursors (notably NMN and NR) can restore mitochondrial function and extend lifespan markers, but human randomized controlled trial data remain limited. A 2023 randomized trial published in Nature Aging (N=30) found oral NMN supplementation raised whole-blood NAD+ levels by roughly 38% vs. Placebo but did not demonstrate significant improvements in functional outcomes at 10 weeks. [7] IV infusions bypass GI absorption and achieve higher peak plasma levels, but no large RCT has demonstrated clinical superiority over the oral route.

Cost Reality

A single NAD+ IV infusion at a wellness clinic runs $200 to $600 depending on dose (typically 250 mg to 1,000 mg over 2 to 4 hours) and location. Rogan has described doing infusions multiple times per week during intensive periods. At even two sessions per week, that is $400 to $1,200 weekly, or $1,600 to $4,800 monthly. No insurance plan in the United States covers NAD+ infusions.

Peptides: BPC-157, Ipamorelin, and What They Cost

Rogan has mentioned peptides including BPC-157, a synthetic peptide derived from a human gastric protein, as part of injury recovery. He has also referenced growth hormone secretagogues. Understanding the regulatory and cost picture here matters.

Regulatory Status

BPC-157 is not FDA-approved for human use. The FDA placed BPC-157 on its list of bulk drug substances that may not be compounded in 2024, citing insufficient evidence of clinical benefit and safety. [8] That regulatory action has complicated access through compounding pharmacies in the United States.

Growth hormone secretagogues like ipamorelin and CJC-1295, which stimulate endogenous GH release rather than supplying exogenous HGH, occupy a similar gray zone. They have been widely prescribed through compounding pharmacies, but the FDA has restricted their compounding status as well.

Cost if Accessed

Before the 2024 FDA actions, compounded BPC-157 peptide vials (typically 5 mg) cost $50 to $150 per month depending on dose and pharmacy. Ipamorelin/CJC-1295 combinations ran $150 to $300 per month. These prices are now largely academic for U.S. Patients seeking legally compounded versions, given the regulatory changes.

Monitoring: What Labs You Actually Need on TRT

Starting TRT without monitoring is not standard-of-care practice. The Endocrine Society 2018 guideline specifies the following surveillance schedule. [1]

Baseline Labs

• Serum total testosterone (morning sample, two measurements on separate days)
• LH and FSH (to classify primary vs. Secondary hypogonadism)
• Hematocrit and hemoglobin
• PSA (men 40 and older)
• Lipid panel and comprehensive metabolic panel

On-Treatment Monitoring

The guideline recommends checking testosterone levels 3 months after starting or changing therapy, then annually once stable. Hematocrit should be monitored at 3 and 6 months: testosterone raises erythropoiesis and a hematocrit above 54% requires dose reduction or phlebotomy. [1] Estradiol monitoring is not explicitly in every guideline but is standard clinical practice because testosterone aromatizes to estradiol; elevated estradiol causes gynecomastia and fluid retention and is typically managed with an aromatase inhibitor like anastrozole 0.5 mg twice weekly.

PSA surveillance: the American Urological Association recommends baseline PSA before TRT initiation in men 40 and older, with follow-up PSA at 3 to 6 months. [6] A PSA rise of more than 1.4 ng/mL above baseline within the first year warrants urology referral.

Lab costs at standard reference labs (Quest, LabCorp) run $150 to $350 for a comprehensive TRT panel without insurance. With insurance, patient cost-share is typically $20 to $80 per draw after deductible.

Side Effects and Risks Every Patient Should Know

TRT carries real risks. The FDA added a labeling requirement in 2015 noting that testosterone products may increase the risk of cardiovascular events and stroke. [9] The evidence base is genuinely mixed.

Cardiovascular Data

The TRAVERSE trial (N=5,246 men with hypogonadism and elevated cardiovascular risk) published in the New England Journal of Medicine in 2023 found that testosterone replacement was non-inferior to placebo for major adverse cardiovascular events over a median 33 months of follow-up. [10] That was reassuring, but the trial also found a higher incidence of atrial fibrillation (3.5% vs. 2.4%), pulmonary embolism (0.9% vs. 0.5%), and acute kidney injury in the testosterone group. [10]

Fertility Impact

Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis and reduces sperm production. Men who want to preserve fertility should discuss clomiphene citrate or hCG-based protocols instead of direct testosterone administration. The American Urological Association guideline on male infertility explicitly states that testosterone therapy is contraindicated in men actively trying to conceive. [11]

Erythrocytosis

Hematocrit elevation is the most common laboratory adverse effect of TRT. A 2021 systematic review in the Journal of Clinical Endocrinology and Metabolism (covering 35 trials, N=5,601) found a relative risk of erythrocytosis of 3.67 (95% CI 2.25 to 5.99) with testosterone vs. Placebo. [12] This is the primary reason hematocrit monitoring every 3 to 6 months is non-negotiable.

Is TRT Right for You? The Clinical Decision

The fact that a high-profile individual uses a therapy is not a clinical indication. Rogan is open about optimizing for performance, body composition, and recovery at a level that exceeds standard hypogonadism management. That context matters.

Who Qualifies by Guideline Criteria

The Endocrine Society and the American Association of Clinical Endocrinologists both require documented biochemical hypogonadism (typically two morning total testosterone measurements below 300 ng/dL) combined with symptoms before initiating TRT. [1] [13] Treating a man with a testosterone of 450 ng/dL who is "just tired" falls outside guideline-supported practice.

The "Optimization" vs. Replacement Distinction

Rogan's stated goal, maintaining peak physical performance in his 50s, represents what some clinicians call "optimization medicine" rather than replacement therapy. This framing pushes target testosterone levels toward the upper quartile of the normal range (700 to 900 ng/dL or above), which carries higher risks of erythrocytosis and cardiovascular strain compared with mid-normal replacement targets. A patient pursuing this approach should have that conversation explicitly with a prescriber and document informed consent.

Finding a Legitimate Prescriber

The American Urological Association and Endocrine Society both publish provider directories. Telehealth TRT clinics can be appropriate for straightforward cases but vary significantly in the rigor of their initial evaluation. A prescriber who issues a testosterone prescription without ordering baseline labs, a symptom assessment, and at minimum a review of cardiovascular history is not following standard of care.

Total Monthly Cost Summary: Rogan-Style Protocol vs. Standard TRT

Putting the numbers together across all components Rogan has discussed:

| Component | Standard Protocol | Rogan-Tier Estimate | |---|---|---| | Testosterone cypionate injection | $40, $80/month | $200, $600/month (concierge) | | Lab monitoring (amortized) | $25, $60/month | $100, $300/month | | Clinic/physician oversight | $30, $100/month | $300, $800/month | | NAD+ IV infusions | Not standard | $1,600, $4,800/month | | Peptides (when accessible) | N/A | $150, $450/month | | Total estimated | $95, $240/month | $2,350, $6,950/month |

The gap is large. Standard medically supervised TRT is affordable. The broader longevity optimization stack Rogan describes is not accessible to most Americans without significant disposable income.